Form 8-K - Current report:
SEC Accession No. 0001641172-25-017786
Filing Date
2025-07-03
Accepted
2025-07-03 16:05:46
Documents
13
Period of Report
2025-07-03
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 43244
2 EX-3.1 ex3-1.htm EX-3.1 11619
  Complete submission text file 0001641172-25-017786.txt   224705

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE aztr-20250703.xsd EX-101.SCH 3017
4 XBRL LABEL FILE aztr-20250703_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE aztr-20250703_pre.xml EX-101.PRE 22360
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3785
Mailing Address 21 BUSINESS PARK DRIVE, SUITE 6 BRANFORD CT 06405
Business Address 21 BUSINESS PARK DRIVE, SUITE 6 BRANFORD CT 06405 (203) 489-0183
Azitra, Inc. (Filer) CIK: 0001701478 (see all company filings)

EIN.: 464478536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41705 | Film No.: 251105582
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)